These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24599547)

  • 1. How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome.
    Cataland SR; Wu HM
    Blood; 2014 Apr; 123(16):2478-84. PubMed ID: 24599547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies.
    Cataland SR; Wu HM
    Eur J Intern Med; 2013 Sep; 24(6):486-91. PubMed ID: 23739653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of complement mediated thrombotic microangiopathies.
    Cataland SR; Wu HM
    Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: an update.
    Tsai HM
    Hematol Oncol Clin North Am; 2013 Jun; 27(3):565-84. PubMed ID: 23714312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.
    Cataland SR; Holers VM; Geyer S; Yang S; Wu HM
    Blood; 2014 Jun; 123(24):3733-8. PubMed ID: 24695849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab.
    Pecoraro C; Ferretti AV; Rurali E; Galbusera M; Noris M; Remuzzi G
    Am J Kidney Dis; 2015 Dec; 66(6):1067-70. PubMed ID: 26409664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome.
    Tsai HM
    Transfus Med Rev; 2014 Oct; 28(4):187-97. PubMed ID: 25280590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.
    Scully M; Goodship T
    Br J Haematol; 2014 Mar; 164(6):759-66. PubMed ID: 24387053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
    Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
    J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
    Laurence J
    Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STEC-HUS, atypical HUS and TTP are all diseases of complement activation.
    Noris M; Mescia F; Remuzzi G
    Nat Rev Nephrol; 2012 Nov; 8(11):622-33. PubMed ID: 22986360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic and Therapeutic Challenges in Atypical Hemolytic Uremic Syndrome: A Case Report].
    Reis S; Ramos D; Cordinhã C; Gomes C
    Acta Med Port; 2019 Oct; 32(10):673-675. PubMed ID: 31625881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Intern Med J; 2018 Jun; 48(6):624-636. PubMed ID: 29582550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathies.
    Rosove MH
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in Pregnancy.
    Scully M
    Semin Thromb Hemost; 2016 Oct; 42(7):774-779. PubMed ID: 27648610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.